
RANI
Rani Therapeutics Holdings Inc.
$0.51
-$0.03(-5.50%)
33
Overall
--
Value
27
Tech
39
Quality
Market Cap
$42.62M
Volume
433.81K
52W Range
$0.39 - $3.75
Target Price
$7.80
Order:
Income Statement
Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|
REVENUE | ||||||
Total Revenue | $2.7M | -- | -- | $1.0M | ||
Total Revenue | $2.7M | -- | -- | $1.0M | ||
GROSS PROFIT | ||||||
Gross Profit | $2.7M | -- | -- | $1.0M | ||
OPERATING EXPENSES | ||||||
Operating Expenses | $54.3M | $63.5M | $66.1M | $54.3M | ||
Research & Development | $26.5M | $36.6M | $39.6M | $26.7M | ||
Research Expense | $26.5M | $36.6M | $39.6M | $26.7M | ||
Selling, General & Administrative | $27.8M | $26.8M | $26.5M | $23.9M | ||
General & Administrative Expenses | $27.8M | $26.8M | $26.5M | $23.9M | ||
Salaries & Wages | $22.6M | $15.8M | $19.0M | $16.0M | ||
Depreciation & Amortization | $500.0K | $500.0K | $800.0K | $1.0M | ||
Depreciation & Amortization | $500.0K | $500.0K | $800.0K | $1.0M | ||
Other Operating Expenses | $-254.0K | $-222.0K | $-260.0K | $-162.0K | ||
OPERATING INCOME | ||||||
Operating income | $-51.6M | $-63.5M | $-66.1M | $-53.3M | ||
EBITDA | $-52.1M | $-61.7M | $-60.7M | $-48.5M | ||
NON-OPERATING ITEMS | ||||||
Interest Expense (Non-Operating) | $466.0K | $1.1M | $5.1M | $5.0M | ||
Intinc | $89.0K | $1.2M | $3.3M | $1.8M | ||
Net Non-Operating Interest Income/Expense | $-377.0K | $177.0K | $-1.8M | $-3.3M | ||
Other Income/Expense | $-329.0K | -- | -- | $-5.0K | ||
Other Special Charges | $329.0K | -- | -- | -- | ||
SPECIAL ITEMS | ||||||
Special Income Charges | -- | -- | -- | $-3.7M | ||
Impairment of Capital Assets | -- | -- | -- | $3.7M | ||
PRE-TAX INCOME | ||||||
EBIT | $-52.6M | $-62.2M | $-62.8M | $-51.6M | ||
Pre-Tax Income | $-53.0M | $-63.3M | $-67.9M | $-56.6M | ||
INCOME TAX | ||||||
Tax Provision | $41.0K | $70.0K | -- | -- | ||
NET INCOME | ||||||
Net Income | $-8.3M | $-30.6M | $-34.0M | $-30.0M | ||
Net Income (Continuing Operations) | $-8.3M | $-63.3M | $-67.9M | $-56.6M | ||
Net Income (Discontinued Operations) | $-8.3M | $-30.6M | $-34.0M | $-30.0M | ||
Net Income (Common Stockholders) | $-6.9M | $-30.6M | $-34.0M | $-30.0M | ||
Normalized Income | $-41.9M | -- | -- | $-52.3M | ||
TOTALS | ||||||
Total Expenses | $54.3M | $63.5M | $66.1M | $54.3M | ||
SHARE & EPS DATA | ||||||
Average Shares Outstanding | $19.5M | $23.8K | $25.5K | $28.5K | ||
Average Shares Outstanding (Diluted) | -- | $23.8K | $25.5K | $28.5K | ||
Shares Outstanding | $49.2M | $49.4M | $47.9M | $57.5M | ||
Basic EPS | $-0.43 | $-1.28 | $-1.33 | $-1.05 | ||
Basic EPS (Continuing Operations) | $-0.43 | $-1.28 | $-1.33 | $-1.05 | ||
Diluted EPS | $-0.43 | $-1.28 | $-1.33 | $-1.05 | ||
Diluted EPS (Continuing Operations) | -- | $-1.28 | $-1.33 | $-1.05 | ||
OTHER METRICS | ||||||
Minority Interests | $44.8M | $32.8M | $33.9M | $26.6M | ||
Other Gand A | $27.8M | $26.8M | $26.5M | $23.9M |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | RANI | $0.51 | -5.5% | 433.81K |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Rani Therapeutics Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW